Literature DB >> 4051602

Management of injuries to the porta hepatis.

G F Sheldon, R C Lim, E S Yee, S R Petersen.   

Abstract

The management of injuries to the porta hepatis is challenging and controversial. Although definitive, anatomic reconstruction of injured ductal or vascular structures is optimal, porta hepatis injuries are universally accompanied by injuries to other organs (3.6 in this series), which often precludes initial repair. Moreover, frequent injury to the inferior vena cava, aorta, or other major blood vessels in addition to the structures of the porta hepatis results in these injuries being treated in conjunction with exsanguinating hemorrhage. For that reason, control of hemorrhage is the initial management priority, with the initial operation requiring expeditious, if less than anatomically exact, operations. Eighteen of 31 patients survived porta hepatis injury. Hepatic artery injuries were treated by ligation. Complex injuries to bile ducts frequently required enteric-ductal anastomoses as secondary procedures. Of 29 patients with portal vein injuries, six were treated by ligation, 22 by lateral repair, and one with splenic vein interposition graft. As in earlier reports, the structure of the porta hepatis associated with the highest morbidity and mortality rates when injured was the portal vein.

Entities:  

Mesh:

Year:  1985        PMID: 4051602      PMCID: PMC1250965          DOI: 10.1097/00000658-198511000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  34 in total

1.  Acute ligation of the portal vein.

Authors:  F R JOHNSTONE
Journal:  Surgery       Date:  1957-06       Impact factor: 3.982

2.  Common duct stricture secondary to blunt abdominal trauma.

Authors:  J R Skow; W P Longmire
Journal:  Am Surg       Date:  1974-10       Impact factor: 0.688

3.  The use of T-tube splints in bile duct repairs.

Authors:  N R Hertzer; H W Gray; S O Hoerr; R E Hermann
Journal:  Surg Gynecol Obstet       Date:  1973-09

4.  Bile duct injury. Results of repair using a changeable stent.

Authors:  R M Stone; Z Cohen; B R Taylor; B Langer; E B Tovee
Journal:  Am J Surg       Date:  1973-02       Impact factor: 2.565

5.  Nonsurgical trauma to the extrahepatic bile ducts.

Authors:  C D Haynes; K S Given; H H Stone; R B Smith
Journal:  South Med J       Date:  1969-11       Impact factor: 0.954

6.  Extrahepatic biliary ductal injury in closed trauma.

Authors:  W P Maier; W P Lightfoot; G P Rosemond
Journal:  Am J Surg       Date:  1968-07       Impact factor: 2.565

7.  Jejunal mucosal graft: a sutureless technic for repair of high bile duct strictures.

Authors:  M J Wexler; R Smith
Journal:  Am J Surg       Date:  1975-02       Impact factor: 2.565

8.  Causes for 340 reoperations on the extrahepatic bile ducts.

Authors:  J Bordley; T T White
Journal:  Ann Surg       Date:  1979-04       Impact factor: 12.969

9.  Lesions of the segmental and lobar hepatic ducts.

Authors:  W P Longmire; R K Tompkins
Journal:  Ann Surg       Date:  1975-10       Impact factor: 12.969

10.  Portal venous system injuries.

Authors:  J M Graham; K L Mattox; A C Beall
Journal:  J Trauma       Date:  1978-06
View more
  3 in total

1.  Portal vein injuries. Noninvasive follow-up of venorrhaphy.

Authors:  R R Ivatury; M Nallathambi; D H Lankin; I Wapnir; M Rohman; W M Stahl
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

Review 2.  Extrahepatic duct injury in blunt trauma: two case reports and a literature review.

Authors:  Thiago Messias Zago; Bruno Monteiro Tavares Pereira; Thiago Rodrigues Araujo Calderan; Elcio Shiyoiti Hirano; Gustavo Pereira Fraga
Journal:  Indian J Surg       Date:  2013-02-21       Impact factor: 0.656

3.  Pancreatic transection from blunt trauma associated with vascular and biliary lesions: a case report.

Authors:  Gian Luca Baiocchi; Guido-Am Tiberio; Federico Gheza; Marco Gardani; Massimiliano Cantù; Nazario Portolani; Stefano Maria Giulini
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.